Literature DB >> 12695023

Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall.

I Grabnar1, M Bogataj, A Mrhar.   

Abstract

Influence of dispersions of mucoadhesive polymers chitosan and polycarbophil on permeability properties of urinary bladder was investigated in vitro on isolated porcine urinary bladder. Pipemidic acid as a model hydrophilic drug was used. Its distribution in the bladder wall was determined from actual tissue concentrations by a method based on sectioning of frozen tissue and extraction of tissue slices. Pipemidic acid tissue concentration versus tissue depth profiles were evaluated by a diffusion model assuming constant diffusion coefficient. Increase in bladder wall permeability was observed in the presence of both polymers. Apparent permeability (mean+/-S.D.) of urinary bladder wall was increased 2.7+/-2.9 and 2.8+/-2.0 times for chitosan, and 2.3+/-2.0 and 4.3+/-4.2 times for polycarbophil at 0.5 and 1.0%, w/v polymer concentration, respectively. This increase is a consequence of the increased permeability of urothelium. These findings support investigations on application of chitosan and polycarbophil in development of mucoadhesive intravesical drug delivery systems. Experimental model may be applied to evaluate the results of experiments with drugs used in intravesical therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695023     DOI: 10.1016/s0378-5173(03)00074-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Authors:  David A Zaharoff; Benjamin S Hoffman; H Brooks Hooper; Compton J Benjamin; Kiranpreet K Khurana; Kenneth W Hance; Connie J Rogers; Peter A Pinto; Jeffrey Schlom; John W Greiner
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

2.  Analyzing the effects of instillation volume on intravesical delivery using biphasic solute transport in a deformable geometry.

Authors:  Sean G Smith; Boyce E Griffith; David A Zaharoff
Journal:  Math Med Biol       Date:  2019-06-13       Impact factor: 1.854

3.  Tissue Permeability Effects Associated with the Use of Mucoadhesive Cationic Nanoformulations of Docetaxel in the Bladder.

Authors:  Rakhi Pandey; John K Jackson; Clement Mugabe; Richard Liggins; Helen M Burt
Journal:  Pharm Res       Date:  2016-04-18       Impact factor: 4.200

Review 4.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

5.  Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery.

Authors:  Tsong-Long Hwang; Chia-Lang Fang; Chao-Huang Chen; Jia-You Fang
Journal:  Pharm Res       Date:  2009-08-04       Impact factor: 4.200

6.  Chitosan-modified dry powder formulations for pulmonary gene delivery.

Authors:  Hao-Ying Li; James Birchall
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.580

Review 7.  NHS-IL12, a Tumor-Targeting Immunocytokine.

Authors:  John W Greiner; Y Maurice Morillon; Jeffrey Schlom
Journal:  Immunotargets Ther       Date:  2021-05-27

Review 8.  Emerging intravesical therapies for management of nonmuscle invasive bladder cancer.

Authors:  Jeffrey J Tomaszewski; Marc C Smaldone
Journal:  Open Access J Urol       Date:  2010-05-19

Review 9.  The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector-Biocompatibility, Bioadhesiveness, and Biodegradability.

Authors:  Gheorghe Adrian Martău; Mihaela Mihai; Dan Cristian Vodnar
Journal:  Polymers (Basel)       Date:  2019-11-08       Impact factor: 4.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.